Iotrolan
Iotrolan
|
| Systematic (IUPAC) name |
| 2,4,6-triiodo-5-{N-methyl-2-[methyl({2,4,6-triiodo-3,5-bis[(1,3,4-trihydroxybutan-2-yl)carbamoyl]phenyl})carbamoyl]acetamido}-1-N,3-N-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide |
| Clinical data |
| AHFS/Drugs.com |
International Drug Names |
| Pregnancy cat. |
Contraindicated |
| Legal status |
℞ Prescription only |
| Identifiers |
| CAS number |
79770-24-4 Y |
| ATC code |
V08AB06 |
| PubChem |
CID 3738 |
| UNII |
16FL47B687 N |
| KEGG |
D01714 Y |
| ChEMBL |
CHEMBL1200555 N |
| Chemical data |
| Formula |
C37H48I6N6O18 |
| Mol. mass |
1626.23 g/mol |
N(what is this?) (verify)
|
Iotrolan (trade name Isovist) is a radiocontrast agent, a substance used to improve the visibility of body structures on images obtained by X-ray techniques. It is particularly used to image spaces surrounding the central nervous system, such as the ventricles, after injection into the cerebrospinal fluid.[1] It can also be used to image joint spaces and in endoscopic retrograde cholangiopancreatography (ERCP).
Chemically, the substance is a dimer of triiodinated isophthalic acid derivatives.
References